Vanessa Walraven

588 total citations
12 papers, 400 citations indexed

About

Vanessa Walraven is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Epidemiology. According to data from OpenAlex, Vanessa Walraven has authored 12 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 4 papers in Hematology and 3 papers in Epidemiology. Recurrent topics in Vanessa Walraven's work include Mosquito-borne diseases and control (4 papers), Malaria Research and Control (4 papers) and Pneumonia and Respiratory Infections (3 papers). Vanessa Walraven is often cited by papers focused on Mosquito-borne diseases and control (4 papers), Malaria Research and Control (4 papers) and Pneumonia and Respiratory Infections (3 papers). Vanessa Walraven collaborates with scholars based in Netherlands, United States and Germany. Vanessa Walraven's co-authors include Elisabeth A. M. Sanders, Clemens H. M. Kocken, Bart W. Faber, Edmond J. Remarque, Alan W. Thomas, Selma P. Wiertsema, Reinier H. Veenhoven, Ronald de Groot, Peter W. M. Hermans and Marieke Emonts and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and PEDIATRICS.

In The Last Decade

Vanessa Walraven

12 papers receiving 397 citations

Peers

Vanessa Walraven
Vanessa Walraven
Citations per year, relative to Vanessa Walraven Vanessa Walraven (= 1×) peers Carolina López

Countries citing papers authored by Vanessa Walraven

Since Specialization
Citations

This map shows the geographic impact of Vanessa Walraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Walraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Walraven more than expected).

Fields of papers citing papers by Vanessa Walraven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Walraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Walraven. The network helps show where Vanessa Walraven may publish in the future.

Co-authorship network of co-authors of Vanessa Walraven

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Walraven. A scholar is included among the top collaborators of Vanessa Walraven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Walraven. Vanessa Walraven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Faber, Bart W., Sumera Younis, Edmond J. Remarque, et al.. (2013). Diversity Covering AMA1-MSP1 19 Fusion Proteins as Malaria Vaccines. Infection and Immunity. 81(5). 1479–1490. 33 indexed citations
2.
Remarque, Edmond J., Meta Roestenberg, Sumera Younis, et al.. (2012). Humoral Immune Responses to a Single Allele PfAMA1 Vaccine in Healthy Malaria-Naïve Adults. PLoS ONE. 7(6). e38898–e38898. 31 indexed citations
3.
Hamid, Muzamil Mahdi Abdel, Edmond J. Remarque, Leonie M. van Duivenvoorde, et al.. (2011). Vaccination with Plasmodium knowlesi AMA1 Formulated in the Novel Adjuvant Co-Vaccine HT™ Protects against Blood-Stage Challenge in Rhesus Macaques. PLoS ONE. 6(5). e20547–e20547. 50 indexed citations
4.
Kusi, Kwadwo Asamoah, Edmond J. Remarque, Vanessa Walraven, et al.. (2011). Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques. Malaria Journal. 10(1). 182–182. 32 indexed citations
5.
Walraven, Vanessa, Elisabeth A. M. Sanders, D.F. van Wichen, et al.. (2011). Expression of CD64 (FcγRI) in skin of patients with acute GVHD. Bone Marrow Transplantation. 46(12). 1566–1569. 2 indexed citations
6.
Emonts, Marieke, Selma P. Wiertsema, Reinier H. Veenhoven, et al.. (2007). The 4G/4G Plasminogen Activator Inhibitor-1 Genotype Is Associated With Frequent Recurrence of Acute Otitis Media. PEDIATRICS. 120(2). e317–e323. 13 indexed citations
7.
Emonts, Marieke, Reinier H. Veenhoven, Selma P. Wiertsema, et al.. (2007). Genetic Polymorphisms in Immunoresponse GenesTNFA,IL6,IL10, andTLR4Are Associated With Recurrent Acute Otitis Media. PEDIATRICS. 120(4). 814–823. 97 indexed citations
8.
Vuuren, Anneke J. van, Joël A. G. van Roon, Vanessa Walraven, et al.. (2006). CD64-Directed Immunotoxin Inhibits Arthritis in a Novel CD64 Transgenic Rat Model. The Journal of Immunology. 176(10). 5833–5838. 41 indexed citations
9.
Royen‐Kerkhof, Annet van, Elisabeth A. M. Sanders, Vanessa Walraven, et al.. (2005). A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcγRIIA transgenic mice. British Journal of Haematology. 130(1). 130–137. 12 indexed citations
10.
Wiertsema, Selma P., Reinier H. Veenhoven, Vanessa Walraven, et al.. (2005). Pneumococcal vaccine efficacy for mucosal pneumococcal infections depends on Fcγ receptor IIa polymorphism. Vaccine. 24(6). 792–797. 12 indexed citations
11.
Royen‐Kerkhof, Annet van, Elisabeth A. M. Sanders, Siska Wijngaarden, et al.. (2004). Flow cytometric determination of FcγRIIa (CD32) polymorphism. Journal of Immunological Methods. 294(1-2). 135–144. 12 indexed citations
12.
Saeland, Eiríkur, Gestur Vidarsson, Jeanette H.W. Leusen, et al.. (2003). Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice. The Journal of Immunology. 170(12). 6158–6164. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026